Prostate carcinoma among men with human immunodeficiency virus infection

Cancer

Volumn 101, Issue 2, 2004, Pages 294-299

  Crum, Nancy F ^a   Spencer, Craig R ^a   Amling, Christopher L ^a  

^a NAVAL MEDICAL CENTER SAN DIEGO   (United States)

Author keywords

Human immunodeficiency virus (HIV); Prostate carcinoma; Prostate specific antigen (PSA); Screening

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; PROSTATE SPECIFIC ANTIGEN; TESTOSTERONE;

ADULT; AFRICAN AMERICAN; AGE DISTRIBUTION; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER SCREENING; COHORT ANALYSIS; DEMOGRAPHY; DIGITAL RECTAL EXAMINATION; DISEASE ASSOCIATION; ETHNOLOGY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LIFE EXPECTANCY; LOGISTIC REGRESSION ANALYSIS; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CARCINOMA; PROSTATITIS; UNITED STATES; VIRUS LOAD;

ADENOCARCINOMA; ADULT; AGE FACTORS; AGED; CD4 LYMPHOCYTE COUNT; CONTINENTAL POPULATION GROUPS; HIV INFECTIONS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TIME FACTORS; UNITED STATES;

EID: 3042781136     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.20389     Document Type: Article

References (34)

1. Centers for Disease Control. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep. 1992,41:1-9.
2. Smith C, Lilly S, Mann KP, et al. AIDS-related malignancies. Ann Med. 1998;30:323-344.
3. Guth AA. Breast cancer and HIV: what do we know? Am Surg. 1999;65:209-211.
4. Monfardini S, Vacher E, Pizzocaro G, et al. Unusual malignant tumours in 49 patients with HIV infection. AIDS. 1989; 3:449-452.
5. Remick SC. Non-AIDS-defining cancers. Hematol Oncol Clin North Am. 1996;10:1203-1213.
6. Demopoulos BP, Vamvakas E, Ehrilich JE, Demopoulos R. Non-acquired immunodeficiency syndrome-defining malignancies in patients infected with human immunodeficiency virus. Arch Pathol Lab Med. 2003;127:589-592.
7. Ricaurte JC, Hoerman MF, Nord JA, Tietjen PA. Lung cancer in HIV-infected patients: a one-year experience. Int J STD AIDS. 2001;12:100-102.
8. Dal Maso L, Franceschi S, Polesel J, et al. Risk of cancer in persons with AIDS in Italy, 1985-1998. Br J Cancer. 2003;89: 94-100.
9. Aaron SD, Warner E, Edelson JD. Bronchogenic carcinoma in patients seropositive for human immunodeficiency virus. Chest. 1994;106:640-642.
10. Hessol NA, Katz MH, Liu JY, Buchbinder SP, Rubino CJ, Holmberg SD. Increased incidence of Hodgkin disease in homosexual men with HIV infection. Ann Intern Med. 1992; 117:301-311.
11. Cooley TP. Non-MDS-defining cancer in HIV-infected people. Hematol Oncol Clin North Am. 2003;17:889-899.
12. El-Rayes BF, Barenji K, Schuman P, Philip PA. Breast cancer in women with human immunodeficiency virus infection: implications for diagnosis and therapy. Breast Cancer Res Treat. 2002;76:111-116.
13. Mbulaiteye SM, Biggar RJ, Goedert JJ, Engels EA. Immune deficiency and risk for malignancy among persons with AIDS. J Acquir Immune Defic Syndr. 2003;32:527-533.
14. Frisch M, Biggar RJ, Engels EA, Goedert JJ, MDS-Cancer Match Registry Study Group. Association of cancer with AIDS-related immunosuppression in adults. JAMA. 2001; 285:1736-1745.
15. Palella FJ Jr., Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 1998; 338:853-860.
16. Jain MK, Skiest DJ, Cloud JW, Jain CL, Burns D, Berggren RE. Changes in mortality related to human immunodeficiency virus infection: comparative analysis of inpatient deaths in 1995 and 1999-2000. Clin Infect Dis. 2003;36:1030-1038.
17. Crum NF, Hale B, Utz G, Wallace M. Increased risk of prostate cancer in HIV infection? [Letter]. AIDS. 2002;16:1703-1704.
18. Ries LAG, Eisner MP, Kosary CL, et al., editors. SEER cancer statistics review, 1975-2000. Bethesda, MD: National Cancer Institute. Available from URL: http://seer.cancer.gov/csr/ 1975_2000 [accessed November 25, 2003].
19. Wistuba II, Behrens C, Gazdar AF. Pathogenesis of non-AIDS-defining cancers: a review. AIDS Patient Care STDS. 1999;13:415-426.
20. Grulich AE, Wan X, Law MG, Coates M, Kaldor JM. Risk of cancer in people with AIDS. AIDS. 1999;13:839-843.
21. Adjiman S, Zerbib M, Flam T, et al. Genitourinary tumors and HIV1 infection. Eur Urol. 1990;18:61-63.
22. Poblet E, Alfaro L, Fernander-Segoviano P, Jimenez-Reyes J, Salido EC. Human papillomavirus-associated penile squamous cell carcinoma in HIV-positive patients. Am J Surg Pathol. 1999;23:1119-1123.
23. Baynham SA, Katner HP, Cleveland KB. Increased prevalence of renal cell carcinoma in patients with HIV infection. AIDS Patient Care STDS. 1997;11:161-165.
24. Hentrich MU, Brack NG, Schmid P, Schuster T, Clemm C, Hartenstein RC. Testicular germ cell tumors in patients with human immunodeficiency virus infection. Cancer. 1996;77: 2109-2116.
25. Pauker SG. Prostatic cancer in a patient with asymptomatic HIV infection: are some lives more equal than others? Med Decis Making. 1988;8:132-144.
26. Gastaut JL, Cesar P, Sobel A, Gray F. Encephalopathie progressive chez un homme de 82 ans ayant une serologi HIV positive et an cancer de la prostate [Progressive encephalopathy in a 82-year-old patient with HIV positive serology and prostatic cancer.]. Rev Neurol. 1991;147:251-257.
27. Schwartz JD, Prince D. Prostate cancer in HIV infection. AIDS. 1996;10:797-798.
28. Catalona WJ, Antenor JV, Roehl KA. Screening for prostate cancer in high risk populations. J Urol. 2002;168:1980-1984.
29. Preston DM, Levin LI, Jacobson DJ, et al. Prostate-specific antigen levels in young white and black men 20 to 45 years old. Urology. 2000;56:812-816.
30. Sakr WA, Haas GP, Cassin BF, Pontes JE, Crissman JD. The frequency of prostate carcinoma and intraepithelial neoplasia of the prostate in young male patients. J Urol. 1993;150: 379-385.
31. Thompson IM, Goodman PJ, Tangen CM, et al. The influence of finasteride on the development of prostate cancer. N Engl J Med. 2003;349:215-224.
32. Nelson WG, De Marzo AM, Issacs WB. Mechanisms of disease: prostate cancer. N Engl J Med. 2003;349:366-381.
33. Platz EA, De Marzo AM. Epidemiology of inflammation and prostate cancer. J Urol. 2004;171:S36-S40.
34. De Marzo AM, Marchi VL, Epstein JI, Nelson WG. Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis. Am J Pathol. 1999;155:1985-1992.